+ cells after in vitro culture in increasing concentrations of 6--hydroxydopamine (6OHDA) (n=3). (D) Survival curve of control and denervated mice where 6OHDA was administered at day 10 and 12 after transplantation (n=5). (E) Quantification of cycling L--GMP from control and denervated mice (normalized to control, n=10). (F) Quantification of Annexin V + L--GMP from control and denervated mice (normalized to control, n=5). (G) Noradrenaline concentration in spleen (left, n=4) and bone marrow extracellular fluid (right, n=4--5) . ***P<0.001 determined by Student's t test. Data are shown as mean ± s.e.m. CFU--F/CFU--OB assay. 1x10 3 sorted cells were seeded per well in a 6--well adherent tissue culture plate using phenol--red free α--MEM (Gibco) supplemented with 20% FBS (Hyclone), 10%
MesenCult stimulatory supplement (StemCell Technologies) and 0.5% penicillin--streptomycin.
One--half of the media was replaced after 7 days and at day 14 cells were stained with Giemsa staining solution (EMD Chemicals). For CFU--OB culture 1 mM ascorbic acid--2--phosphate was added, with one--half media change every week for 28 days. Staining for alkaline phosphatase was performed according to manufacturer's recommendations (Sigma Aldrich), von Kossa staining was done with 2.5% weight/volume AgNO 3 incubation for 30 min.
Cell differentiation. For osteogenic, adipogenic and chondrogenic differentiation, mouse Nes--GFP + cells, isolated from CFU--F cultures of control or leukemic mice, were treated with stemXvivo osteogenic, adipogenic or chondrogenic differentiation media, according to manufacturer's instructions (R&D Systems). All cultures were maintained with 5% CO 2 in a water--jacketed incubator at 37°C for 4--6 weeks and half--medium changes were performed bi-- 
LTC--IC assay.
To determine LTC--IC frequencies, serial dilutions of sorted GFP --bone marrow cells isolated from control and AML mice were plated on single--well stromal cultures; 4 weeks later each individual well was assayed for the presence of CFU--C as described (Miller et al., 2008 RNA isolation and quantitative real--time PCR. Sorted cells were collected in lysis buffer and RNA isolation was performed using the Dynabeads® mRNA DIRECT™ Micro Kit (Invitrogen).
Reverse transcription was performed using the RNA to cDNA EcoDry™ Premix system (Clontech), following the manufacturer's recommendations. Quantitative real--time PCR was performed as previously described (Mendez--Ferrer et al., 2010) . The relative mRNA abundance was calculated using the ΔCt method. Gene expression data was normalized to Gapdh. Primer sequences are included below. Immunofluorescence staining. Tissues were fixed with 4% PFA via perfusion, and femoral or tibial bone tissues were further fixed with 4% PFA for 30 min at 4°C, and incubated in 10%, 20%, and 30% sucrose each for 1h at 4°C for cryoprotection and embedded in 5% carboxymethyl cellulose (SECTION--LAB). Sections, 20--30 µm thick, were prepared using Kawamoto's film method (Kawamoto and Shimizu, 2000) . Anti--mouse osteocalcin antibody (R21C--01A, Takara) and anti--perilipin antibody (D1D8, Cell Signaling) were used. Images were acquired using a laser--scanning confocal microscope (SP5 AOBS, Leica), Leica LAS--AF software (Leica), and image J (Schneider et al., 2012) . For staining of sympathetic nerve fibers, sections were incubated with anti--tyrosine hydroxylase antibody (AB152, Millipore) for 72h. Images were acquired using a ZEISS AXIO examiner D1 microscope (Zeiss) with a confocal scanner unit, CSUX1CU (Yokogawa) and reconstructed in three dimensions with Slide Book software (Intelligent Imaging Innovations). For whole--mount tissue preparation of the sternum, sternal bones were collected and transected with a surgical blade into 2-3 fragments. The fragments were bisected sagittally to expose the bone marrow cavity, fixed in 4% PFA and stained as previously described (Kunisaki et al., 2013) . Whole--mount tissue preparation of the cremaster muscle was performed as previously described (Scheiermann et al., 2012) .
Mouse primers
Histology and Immunohistochemistry. Cleaned bones were fixed in 10% neutral buffered formalin for 24h and decalcified in 10% EDTA. Tissues were then processed and embedded in paraffin. 5--µm thick sections were cut and used for H&E or tartrate--resistant acid phosphatase (TRAP) staining.
Noradrenaline measurements. Spleens and BMEF were rapidly harvested and frozen in liquid
nitrogen. Tissues were homogenized in HPLC solvent. Noradrenaline levels were determined by HPLC at the Neurochemistry Core Laboratory, Vanderbilt University's Center for Molecular
Neuroscience Research (Nashville, TN).
MicroCT analysis. Bones were fixed in 10% neutral buffered formalin for 24h and then kept in 70% ethanol at 4°C. The bone samples were scanned using a high--resolution SkyScan micro--CT system. Images were acquired using a 10 MP digital detector, 10 W power energy (100 kV and 100 µA) and a 0.5 mm aluminum filter. X--ray projections were generated from the sample each 0.3 degrees, obtaining 297 consecutive slices with a 6.82 µm image pixel size. Five exposures by projection (1767 ms exposure time) were used to produce high--contrast low--noise images.
Trabecular and cortical regions were defined as positions along the long axis of the femur relative to the growth plate reference. The cortical region of interest was selected as ± 1.0 mm
